Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records

Background: Clozapine is the gold-standard medication for treatment-resistant schizophrenia (TRS) yet its initiation is often delayed. Objective: To examine whether earlier initiation of clozapine in TRS is associated with lower Clinical Global Impression – Severity (CGI-S) scores at 2 years. Method...

Full description

Bibliographic Details
Main Authors: Rowena Jones, Rachel Upthegrove, Malcolm J. Price, Megan Pritchard, Joht Singh Chandan, Sophie Legge, James H. MacCabe
Format: Article
Language:English
Published: SAGE Publishing 2022-06-01
Series:Therapeutic Advances in Psychopharmacology
Online Access:https://doi.org/10.1177/20451253221103353
_version_ 1829462388901937152
author Rowena Jones
Rachel Upthegrove
Malcolm J. Price
Megan Pritchard
Joht Singh Chandan
Sophie Legge
James H. MacCabe
author_facet Rowena Jones
Rachel Upthegrove
Malcolm J. Price
Megan Pritchard
Joht Singh Chandan
Sophie Legge
James H. MacCabe
author_sort Rowena Jones
collection DOAJ
description Background: Clozapine is the gold-standard medication for treatment-resistant schizophrenia (TRS) yet its initiation is often delayed. Objective: To examine whether earlier initiation of clozapine in TRS is associated with lower Clinical Global Impression – Severity (CGI-S) scores at 2 years. Methods: This was a retrospective cohort study from electronic health records of patients with first adequate trial of clozapine at the South London and Maudsley mental health service between 1 January 2007 and 31 December 2016. Dates of illness onset and clozapine commencement were manually extracted from anonymised case notes. CGI-S scores were rated blind to illness duration. Ordinal logistic regression was used to describe the association between illness duration at baseline and CGI-S outcome score at 2 years, following adjustment for CGI-S start score and other key covariates. Results: Among the 401 patients included, there was an association between illness duration and CGI-S outcome score with a 4% increase in the odds of a higher (worse) outcome CGI-S score per year of illness [adjusted odds ratio (AOR) = 1.04; 95% confidence interval (CI): 1.01–1.06]. The association between illness duration and clozapine response was most marked at less than 4 years illness duration. There were too few clozapine initiations within the first 2 years of illness to draw any conclusions about early clozapine initiation. Conclusion: Initiation of clozapine within 2–4 years of psychotic illness onset offers the best outcome for TRS, but the advantage, if any, of earlier initiation is unclear from these data.
first_indexed 2024-12-12T12:09:07Z
format Article
id doaj.art-dbc3319030df4625b74688c938fbc746
institution Directory Open Access Journal
issn 2045-1261
language English
last_indexed 2024-12-12T12:09:07Z
publishDate 2022-06-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Psychopharmacology
spelling doaj.art-dbc3319030df4625b74688c938fbc7462022-12-22T00:24:56ZengSAGE PublishingTherapeutic Advances in Psychopharmacology2045-12612022-06-011210.1177/20451253221103353Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health recordsRowena JonesRachel UpthegroveMalcolm J. PriceMegan PritchardJoht Singh ChandanSophie LeggeJames H. MacCabeBackground: Clozapine is the gold-standard medication for treatment-resistant schizophrenia (TRS) yet its initiation is often delayed. Objective: To examine whether earlier initiation of clozapine in TRS is associated with lower Clinical Global Impression – Severity (CGI-S) scores at 2 years. Methods: This was a retrospective cohort study from electronic health records of patients with first adequate trial of clozapine at the South London and Maudsley mental health service between 1 January 2007 and 31 December 2016. Dates of illness onset and clozapine commencement were manually extracted from anonymised case notes. CGI-S scores were rated blind to illness duration. Ordinal logistic regression was used to describe the association between illness duration at baseline and CGI-S outcome score at 2 years, following adjustment for CGI-S start score and other key covariates. Results: Among the 401 patients included, there was an association between illness duration and CGI-S outcome score with a 4% increase in the odds of a higher (worse) outcome CGI-S score per year of illness [adjusted odds ratio (AOR) = 1.04; 95% confidence interval (CI): 1.01–1.06]. The association between illness duration and clozapine response was most marked at less than 4 years illness duration. There were too few clozapine initiations within the first 2 years of illness to draw any conclusions about early clozapine initiation. Conclusion: Initiation of clozapine within 2–4 years of psychotic illness onset offers the best outcome for TRS, but the advantage, if any, of earlier initiation is unclear from these data.https://doi.org/10.1177/20451253221103353
spellingShingle Rowena Jones
Rachel Upthegrove
Malcolm J. Price
Megan Pritchard
Joht Singh Chandan
Sophie Legge
James H. MacCabe
Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
Therapeutic Advances in Psychopharmacology
title Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
title_full Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
title_fullStr Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
title_full_unstemmed Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
title_short Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
title_sort duration of prior psychotic illness and clozapine response a retrospective observational study using electronic health records
url https://doi.org/10.1177/20451253221103353
work_keys_str_mv AT rowenajones durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords
AT rachelupthegrove durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords
AT malcolmjprice durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords
AT meganpritchard durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords
AT johtsinghchandan durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords
AT sophielegge durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords
AT jameshmaccabe durationofpriorpsychoticillnessandclozapineresponsearetrospectiveobservationalstudyusingelectronichealthrecords